| Product Code: ETC10401524 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Recombinant Coagulation Factors Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Recombinant Coagulation Factors Market - Industry Life Cycle |
3.4 Vietnam Recombinant Coagulation Factors Market - Porter's Five Forces |
3.5 Vietnam Recombinant Coagulation Factors Market Revenues & Volume Share, By Coagulation Factor, 2021 & 2031F |
3.6 Vietnam Recombinant Coagulation Factors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Vietnam Recombinant Coagulation Factors Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Vietnam Recombinant Coagulation Factors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hemophilia and other bleeding disorders in Vietnam |
4.2.2 Growing awareness about the benefits of recombinant coagulation factors over traditional treatments |
4.2.3 Technological advancements in recombinant coagulation factor production and delivery |
4.3 Market Restraints |
4.3.1 High cost associated with recombinant coagulation factors |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Vietnam |
4.3.3 Stringent regulatory requirements for the approval and commercialization of recombinant coagulation factors |
5 Vietnam Recombinant Coagulation Factors Market Trends |
6 Vietnam Recombinant Coagulation Factors Market, By Types |
6.1 Vietnam Recombinant Coagulation Factors Market, By Coagulation Factor |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Coagulation Factor, 2021 - 2031F |
6.1.3 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Factor VIII, 2021 - 2031F |
6.1.4 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Factor IX, 2021 - 2031F |
6.1.5 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Factor VIIa, 2021 - 2031F |
6.2 Vietnam Recombinant Coagulation Factors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Hemophilia A, 2021 - 2031F |
6.2.3 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Hemophilia B, 2021 - 2031F |
6.2.4 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Factor VII Deficiency, 2021 - 2031F |
6.3 Vietnam Recombinant Coagulation Factors Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.3 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.4 Vietnam Recombinant Coagulation Factors Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
7 Vietnam Recombinant Coagulation Factors Market Import-Export Trade Statistics |
7.1 Vietnam Recombinant Coagulation Factors Market Export to Major Countries |
7.2 Vietnam Recombinant Coagulation Factors Market Imports from Major Countries |
8 Vietnam Recombinant Coagulation Factors Market Key Performance Indicators |
8.1 Patient adherence rates to recombinant coagulation factor therapy |
8.2 Number of healthcare providers trained in the administration of recombinant coagulation factors |
8.3 Time to market for new recombinant coagulation factor products |
8.4 Rate of adoption of recombinant coagulation factors in place of traditional treatments |
8.5 Number of clinical trials and research studies on recombinant coagulation factors conducted in Vietnam |
9 Vietnam Recombinant Coagulation Factors Market - Opportunity Assessment |
9.1 Vietnam Recombinant Coagulation Factors Market Opportunity Assessment, By Coagulation Factor, 2021 & 2031F |
9.2 Vietnam Recombinant Coagulation Factors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Vietnam Recombinant Coagulation Factors Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Vietnam Recombinant Coagulation Factors Market - Competitive Landscape |
10.1 Vietnam Recombinant Coagulation Factors Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Recombinant Coagulation Factors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here